271 related articles for article (PubMed ID: 37046623)
1. Chondrosarcoma Resistance to Radiation Therapy: Origins and Potential Therapeutic Solutions.
Gilbert A; Tudor M; Montanari J; Commenchail K; Savu DI; Lesueur P; Chevalier F
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046623
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of chondrosarcoma cells with PARP inhibitor and high-LET radiation.
Césaire M; Ghosh U; Austry JB; Muller E; Cammarata FP; Guillamin M; Caruso M; Castéra L; Petringa G; Cirrone GAP; Chevalier F
J Bone Oncol; 2019 Aug; 17():100246. PubMed ID: 31312595
[TBL] [Abstract][Full Text] [Related]
3. High LET Radiation Overcomes
Chevalier F; Hamdi DH; Lepleux C; Temelie M; Nicol A; Austry JB; Lesueur P; Vares G; Savu D; Nakajima T; Saintigny Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819871309. PubMed ID: 31495269
[TBL] [Abstract][Full Text] [Related]
4. A multimodal treatment of carbon ions irradiation, miRNA-34 and mTOR inhibitor specifically control high-grade chondrosarcoma cancer stem cells.
Vares G; Ahire V; Sunada S; Ho Kim E; Sai S; Chevalier F; Romeo PH; Yamamoto T; Nakajima T; Saintigny Y
Radiother Oncol; 2020 Sep; 150():253-261. PubMed ID: 32717360
[TBL] [Abstract][Full Text] [Related]
5. In vitro engineering of human 3D chondrosarcoma: a preclinical model relevant for investigations of radiation quality impact.
Hamdi DH; Barbieri S; Chevalier F; Groetz JE; Legendre F; Demoor M; Galera P; Lefaix JL; Saintigny Y
BMC Cancer; 2015 Aug; 15():579. PubMed ID: 26253487
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship study of hypoxia-activated prodrugs for proteoglycan-targeted chemotherapy in chondrosarcoma.
Ghedira D; Voissière A; Peyrode C; Kraiem J; Gerard Y; Maubert E; Vivier M; Miot-Noirault E; Chezal JM; Farhat F; Weber V
Eur J Med Chem; 2018 Oct; 158():51-67. PubMed ID: 30199705
[TBL] [Abstract][Full Text] [Related]
7. Differential bystander signaling between radioresistant chondrosarcoma cells and fibroblasts after x-ray, proton, iron ion and carbon ion exposures.
Wakatsuki M; Magpayo N; Kawamura H; Held KD
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e103-8. PubMed ID: 22537542
[TBL] [Abstract][Full Text] [Related]
8. Pelvic chondrosarcomas: surgical treatment options.
Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
[TBL] [Abstract][Full Text] [Related]
9. Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma.
Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M
J Cancer Res Clin Oncol; 1999 Oct; 125(10):541-8. PubMed ID: 10473866
[TBL] [Abstract][Full Text] [Related]
10. Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma.
Cleton-Jansen AM; van Beerendonk HM; Baelde HJ; Bovée JV; Karperien M; Hogendoorn PC
Clin Cancer Res; 2005 Nov; 11(22):8028-35. PubMed ID: 16299232
[TBL] [Abstract][Full Text] [Related]
11. Hadrontherapy in the world and the programmes of the TERA Foundation.
Amaldi U
Tumori; 1998; 84(2):188-99. PubMed ID: 9620244
[TBL] [Abstract][Full Text] [Related]
12. Label-Free Direct Mass Spectrometry Analysis of the Bystander Effects Induced in Chondrocytes by Chondrosarcoma Cells Irradiated with X-rays and Carbon Ions.
Gilbert A; Payet V; Bernay B; Chartier-Garcia E; Testard I; Candéias SM; Chevalier F
Front Biosci (Landmark Ed); 2022 Sep; 27(9):277. PubMed ID: 36224025
[TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy for sarcoma: hadrontherapy, for whom and what for?].
Pommier P; Sunyach MP; Hu Y; Amsalem E; Claude L; Moncort-Boulch D; Toutenu P; Balosso J
Bull Cancer; 2010 Jun; 97(6):657-72. PubMed ID: 20547480
[TBL] [Abstract][Full Text] [Related]
14. Chondrosarcoma: A Rare Misfortune in Aging Human Cartilage? The Role of Stem and Progenitor Cells in Proliferation, Malignant Degeneration and Therapeutic Resistance.
Boehme KA; Schleicher SB; Traub F; Rolauffs B
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361725
[TBL] [Abstract][Full Text] [Related]
15. Imaging issues specific to hadrontherapy (proton, carbon, helium therapy and other charged particles) for radiotherapy planning, setup, dose monitoring and tissue response assessment.
Thariat J; Hérault J; Beddok A; Feuvret L; Dauvergne D; Gérard M; Balosso J; Noël G; Valable S
Cancer Radiother; 2020 Aug; 24(5):429-436. PubMed ID: 32247687
[TBL] [Abstract][Full Text] [Related]
16. A cartilage-forming tumor of the mandibular angle: a case report.
Ismail A; Boujguenna I; Hattab K; Mansouri N; El Ganouni NCI; Idrissi MO; Hazmiri FE; Rais H
J Med Case Rep; 2022 Apr; 16(1):176. PubMed ID: 35484609
[TBL] [Abstract][Full Text] [Related]
17. New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance.
Monderer D; Luseau A; Bellec A; David E; Ponsolle S; Saiagh S; Bercegeay S; Piloquet P; Denis MG; Lodé L; Rédini F; Biger M; Heymann D; Heymann MF; Le Bot R; Gouin F; Blanchard F
Lab Invest; 2013 Oct; 93(10):1100-14. PubMed ID: 23958880
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium-based nanoparticles to improve the hadrontherapy performances.
Porcel E; Tillement O; Lux F; Mowat P; Usami N; Kobayashi K; Furusawa Y; Le Sech C; Li S; Lacombe S
Nanomedicine; 2014 Nov; 10(8):1601-8. PubMed ID: 24846523
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genes.
de Jong Y; Ingola M; Briaire-de Bruijn IH; Kruisselbrink AB; Venneker S; Palubeckaite I; Heijs BPAM; Cleton-Jansen AM; Haas RLM; Bovée JVMG
Clin Sarcoma Res; 2019; 9():9. PubMed ID: 31160965
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP receptor in cartilaginous tumours: a marker for malignancy?
Kunisada T; Moseley JM; Slavin JL; Martin TJ; Choong PF
Pathology; 2002 Apr; 34(2):133-7. PubMed ID: 12009094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
